Genelab’s Lupus Drug Enters Japanese Market
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 45 (Table of Contents)
Published: 4 Mar-2004
DOI: 10.3833/pdr.v2004.i45.824 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Genelabs Technologies licensed the exclusive Japanese marketing rights to Prestara™ (prasterone), its investigational steroid hormone immunosuppressive drug for systemic lupus erythematosus to Tanabe Seiyaku...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS